Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CareRA2020: Etanercept vs Leflunomide for Early RA Insufficient Responders
NCT03649061Phase 4Completed
- Start
- Jun 2018
- Primary completion
- Jul 2022
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept in rheumatoid arthritis (RA). Started Jun 2018; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03649061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03649061.